Printer Friendly Version Template

Here's your prescription to save.

Saving is easy when you enroll in our program, not to mention the valuable support you'll receive along the way. Not only will you get up to $240 in savings over one year toward your AndroGel prescription, but you'll also receive refill reminders and educational emails regarding Low T. Those are three good reasons to sign up and save today. Certain restrictions apply.*

Please choose the option below that describes you best in order to access relevant information on AndroGel and Low T. You may also be eligible to enroll in the Patient Support and Savings Program:*

Having problems with your Savings Card? No problem. While technology is great, sometimes there are glitches. If you're having technical difficulty using your card at the pharmacy, you'll need to use our rebate form instead. Simply print out the form and follow the directions, and your savings can begin. Go to the rebate form now.

*Certain restrictions apply. Offer not valid for prescriptions eligible to be reimbursed, in whole or in part, by Medicare, Medicaid, any other federal or state program, or by private plans or other health or pharmacy benefit programs which reimburse you for the entire cost of your prescription drugs. Offer void in Massachusetts for residents whose prescriptions are covered in whole or in part by third-party insurance, or where otherwise prohibited by law. See complete Terms and Conditions section.

IMPORTANT SAFETY INFORMATION

Signs of puberty that are not expected have been reported in young children who were accidentally exposed to testosterone through contact with men using AndroGel. AndroGel can transfer from the patient's body to others. This can happen if other people come into contact with the area where the AndroGel was applied. Women and children should avoid contact with the unwashed or unclothed application area where AndroGel has been applied. Patients must strictly follow the recommended instructions for use.

AndroGel must not be used in men with breast cancer. Also, AndroGel must not be used in men that have or might have prostate cancer. In addition, AndroGel must not be used in pregnant women, those who may become pregnant, or those who are breastfeeding, since testosterone can cause harm to the unborn or breastfeeding baby. Patients should not use AndroGel if they are allergic to any of the ingredients in AndroGel, including soy. AndroGel is not approved for use in women.

To lower the risk of transfer of AndroGel, patients should apply AndroGel only to areas that will be covered by a short sleeve T-shirt. These areas include shoulders, upper arms, and stomach area. Patients should wash their hands right away with soap and water after applying AndroGel. After the gel has dried, patients should cover the application area with clothing. If patients expect to have skin-to-skin contact with another person the patient should first wash the application area well with soap and water. If a woman or child makes contact with the AndroGel application area, that area on the woman or child should be washed well with soap and water right away. The patient should stop using AndroGel and call their healthcare provider right away if they see any signs or symptoms in children or women that may have occurred through accidental exposure to AndroGel.

Other risks associated with the use of testosterone include prostate enlargement and prostate cancer.

The most common side effects reported with use of AndroGel are acne, skin irritation where the gel is applied, increased cholesterol levels, increased prostate specific antigen, increased red blood cell count, and increased liver function tests.

AndroGel is approved for replacement therapy in adult males for conditions associated with low or absent testosterone in the body.

Please see full Prescribing Information including the Medication Guide.

If you have any questions about this information, be sure to discuss them with your doctor. You are encouraged to report suspected adverse reactions to Solvay Pharmaceuticals, Inc. at 1-800-241-1643 or the FDA at www.fda.gov/medwatch or call 1-800-FDA-1088.
This information is intended for residents of the United States.
For international product information please visit us at http://www.solvay.com.
© 2009 Solvay Pharmaceuticals, Inc.


	Print this page >	Back to site >
AndroGel Extras
Sign up for the AndroGel Patient Support and Savings Program today. Here's your prescription to save. Saving is easy when you enroll in our program, not to mention the valuable support you'll receive along the way. Not only will you get up to $240 in savings over one year toward your AndroGel prescription, but you'll also receive refill reminders and educational emails regarding Low T. Those are three good reasons to sign up and save today. Certain restrictions apply.* Please choose the option below that describes you best in order to access relevant information on AndroGel and Low T. You may also be eligible to enroll in the Patient Support and Savings Program:* Having problems with your Savings Card? No problem. While technology is great, sometimes there are glitches. If you're having technical difficulty using your card at the pharmacy, you'll need to use our rebate form instead. Simply print out the form and follow the directions, and your savings can begin. Go to the rebate form now. *Certain restrictions apply. Offer not valid for prescriptions eligible to be reimbursed, in whole or in part, by Medicare, Medicaid, any other federal or state program, or by private plans or other health or pharmacy benefit programs which reimburse you for the entire cost of your prescription drugs. Offer void in Massachusetts for residents whose prescriptions are covered in whole or in part by third-party insurance, or where otherwise prohibited by law. See complete Terms and Conditions section.

IMPORTANT SAFETY INFORMATION Signs of puberty that are not expected have been reported in young children who were accidentally exposed to testosterone through contact with men using AndroGel. AndroGel can transfer from the patient's body to others. This can happen if other people come into contact with the area where the AndroGel was applied. Women and children should avoid contact with the unwashed or unclothed application area where AndroGel has been applied. Patients must strictly follow the recommended instructions for use. AndroGel must not be used in men with breast cancer. Also, AndroGel must not be used in men that have or might have prostate cancer. In addition, AndroGel must not be used in pregnant women, those who may become pregnant, or those who are breastfeeding, since testosterone can cause harm to the unborn or breastfeeding baby. Patients should not use AndroGel if they are allergic to any of the ingredients in AndroGel, including soy. AndroGel is not approved for use in women. To lower the risk of transfer of AndroGel, patients should apply AndroGel only to areas that will be covered by a short sleeve T-shirt. These areas include shoulders, upper arms, and stomach area. Patients should wash their hands right away with soap and water after applying AndroGel. After the gel has dried, patients should cover the application area with clothing. If patients expect to have skin-to-skin contact with another person the patient should first wash the application area well with soap and water. If a woman or child makes contact with the AndroGel application area, that area on the woman or child should be washed well with soap and water right away. The patient should stop using AndroGel and call their healthcare provider right away if they see any signs or symptoms in children or women that may have occurred through accidental exposure to AndroGel. Other risks associated with the use of testosterone include prostate enlargement and prostate cancer. The most common side effects reported with use of AndroGel are acne, skin irritation where the gel is applied, increased cholesterol levels, increased prostate specific antigen, increased red blood cell count, and increased liver function tests. AndroGel is approved for replacement therapy in adult males for conditions associated with low or absent testosterone in the body. Please see full Prescribing Information including the Medication Guide. If you have any questions about this information, be sure to discuss them with your doctor. You are encouraged to report suspected adverse reactions to Solvay Pharmaceuticals, Inc. at 1-800-241-1643 or the FDA at www.fda.gov/medwatch or call 1-800-FDA-1088. This information is intended for residents of the United States. For international product information please visit us at http://www.solvay.com. © 2009 Solvay Pharmaceuticals, Inc.